These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6891739)

  • 1. Effects of beta-chlornaltrexamine on separation distress in chicks.
    Panksepp J; Siviy S; Normansell L; White K; Bishop P
    Life Sci; 1982 Nov 15-22; 31(20-21):2387-90. PubMed ID: 6891739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine.
    Larson AA; Armstrong MJ
    Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.
    Tulunay FC; Ayhan IH; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1981 Mar; 70(2):219-24. PubMed ID: 6266844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties.
    Portoghese PS; Larson DL; Jiang JB; Caruso TP; Takemori AE
    J Med Chem; 1979 Feb; 22(2):168-73. PubMed ID: 218009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Jun; 80(4):377-84. PubMed ID: 6286325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the novel irreversible opiate antagonist, beta-chlornaltrexamine, in the estimation of the normorphine affinity constant in naive and morphine tolerant guinea-pig ilea.
    Porreca F; Burks TF
    Proc West Pharmacol Soc; 1983; 26():295-7. PubMed ID: 6684293
    [No Abstract]   [Full Text] [Related]  

  • 8. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
    Valentino RJ; Herling S; Woods JH; Medzihradsky F; Merz H
    J Pharmacol Exp Ther; 1981 Jun; 217(3):652-9. PubMed ID: 6262493
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators.
    Messing RB; Portoghese PS; Takemori AE; Sparber SB
    Pharmacol Biochem Behav; 1982 Apr; 16(4):621-6. PubMed ID: 6280206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of separation distress by alpha-MSH.
    Panksepp J; Abbott BB
    Peptides; 1990; 11(4):647-53. PubMed ID: 2172935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6beta-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan(chlornaltrexamine) a potent opioid receptor alkylating agent with ultralong narcotic antagonist actitivty.
    Portoghese PS; Larson DL; Jiang JB; Takemori AE; Caruso TP
    J Med Chem; 1978 Jul; 21(7):598-9. PubMed ID: 209185
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat.
    Ramarao P; Bhargava HN
    Pharmacology; 1988; 37(1):1-7. PubMed ID: 3420162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casomorphins reduce separation distress in chicks.
    Panksepp J; Normansell L; Siviy S; Rossi J; Zolovick AJ
    Peptides; 1984; 5(4):829-31. PubMed ID: 6541784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice.
    Menendez L; Andres-Trelles F; Hidalgo A; Baamonde A
    Brain Res; 1993 May; 611(2):264-71. PubMed ID: 8392894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
    Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
    Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.